Red Flags Detected
- Auditor Change (new) — Company switched from Bush & Associates to M&K CPAS for 2025; new auditor identified revenue recognition as critical audit matter while prior auditor reported none.
- Asset Impairment (new) — Recorded $1.75M intangible asset impairment (46% of prior balance) after determining certain product licenses could not be commercialized.
Sunshine Biopharma cuts pipeline 66%, faces $5.3M legal claim, narrows loss despite revenue growth
Filed April 3, 2026 · Period ending December 31, 2025 · Compared to 10-K Apr 1, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade SBFMW commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 3, 2026 7:44 PM